Shree Pacetronix Ltd.
Snapshot View

View in App

Prices View details >>

99.75 -0.35 ▼-0.4%

31 March 2023, 04:01:00 PM
Volume: 4,817

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Medical Equipment/Supplies/Accessories Compare with Industry peers
Website http://www.pacetronix.com
Market Cap 35.13 Cr.
Enterprise Value(EV) 36.85 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 4.46 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 22.34 Trailing Twelve Months Ending 2022-12
Industry PE 58.79 Trailing Twelve Months Ending 2022-12
Book Value / Share 21.43 Trailing Twelve Months Ending 2022-12
Price to Book Value 4.65 Calculated using Price: 99.75
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.36 Cr. 3,599,400 Shares
FaceValue 10
Company Profile
Shree Pacetronix was incorporated on January 11, 1988 as a Pvt. Ltd. company. In 1993 the company was converted to a Public Limited Company. The company is listed on Bombay Stock Exchange and regional exchanges and has strength of about 7000 shareholders today.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.35%
1 Week
+0.81%
1 Month
-3.67%
3 Month
-1.97%
6 Month
+61.02%
1 Year
+390.17%
2 Year
+762.14%
5 Year
+691.67%
10 Year
+353.41%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 4.29 -1.11 -1.61 -6.34 2.61 2.68 4.34 0.95 12.96
Return on Capital Employed (%) 10.61 3.82 4.18 -0.64 6.51 6.63 8.05 5.46 14.81
Return on Assets (%) 2.52 -0.67 -0.97 -3.79 1.48 1.43 2.23 0.49 6.90

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 5 5 5 5 5 5 6 6 6 7
Non Curr. Liab. 0 0 0 0 1 1 0 0 0 0
Curr. Liab. 3 3 3 3 3 4 5 5 5 7
Minority Int.
Equity & Liab. 9 9 9 9 9 10 11 11 12 14
Non Curr. Assets 4 3 3 3 3 4 4 5 4 5
Curr. Assets 5 6 6 6 6 7 6 6 7 9
Misc. Exp. not W/O
Total Assets 9 9 9 9 9 10 11 11 12 14

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 8 7 7 7 7 7 9 8 9 15
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 8 7 7 7 7 7 9 8 9 15
Total Expenditure -7 -6 -6 -6 -6 -7 -8 -7 -7 -12
PBIDT 1 1 1 1 1 1 1 1 2 3
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation -1 -1 -1 -1 0 0 -1 -1 -1 -1
Taxation 0 0 0 0 0 0 0 0 0 -1
Exceptional Items
PAT 0 0 0 0 0 0 0 0 1 2
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 0 0 0 0 0 0 0 0 1 2
Adjusted EPS 1 0 0 -1 0 0 1 0 2 4

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 1 1 0 1 0 1 0 2 1 2
Cash Fr. Inv. 0 0 0 0 -1 -1 -1 -1 -1 0
Cash Fr. Finan. -1 -1 0 -1 0 -1 0 -1 0 0
Net Change 0 0 0 0 0 0 0 0 0 1
Cash & Cash Eqvt 0 0 0 0 0 0 0 1 1 2

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 24.25 24.25 24.25 24.25 24.25 24.25 24.25 24.25 24.25
Public 75.75 75.75 75.75 75.75 75.75 75.75 75.75 75.75 75.75
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 30 Mar 2023
Closure of Trading Window
Pursuant to the SEBI (Prohibition of Insider Trading) Regulations 2015 as amended we wish to inform that the Trading Window for dealing in securities of the Company shall be closed for Designated Persons viz. Directors Promoters KMPs Designated Employees and Connected persons including their immediate relatives and Material Subsidiary of the Company commencing from 01stApril 2023 till the announcement/declaration to the Stock Exchange of the Standalone and Consolidated Audited Financial Results of the Company for the quarter and year ended March 31 2023 and 48 hours thereafter. The date of the Board Meeting of the Company for announcement/declaration to the Stock Exchange of Standalone and Consolidated Audited Financial Results for the quarter and year ended March 31 2023 will be intimated in due course.
Fri, 17 Mar 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
In compliance with the provisions of Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/2022/8 dated January 25 2022 and based on the intimation received from Registrar and Transfer Agents (RTA) M/s. Ankit Consultancy Private Limited this is to inform you that the below shareholder has reported the misplaced/lost of its share certificate and has requested us to issue duplicate share certificate in lieu of original of Mr. Rajesh Kumar Lunawat(Folio No.R005118) and Mr Kamal Biswas(Folio No.K001126 K003170) as enclosed in PDF.
Thu, 09 Mar 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
In compliance with the provisions of Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/2022/8 dated January 25 2022 and based on the intimation received from Registrar and Transfer Agents (RTA) M/s. Ankit Consultancy Private Limited this is to inform you that the below shareholder has reported the misplaced/lost of its share certificate and has requested us to issue duplicate share certificate in lieu of original of Ms. Sarita Rani (Folio No.Z5409) as enclosed in Pdf.

Technical Scans View Details >>

Fri, 31 Mar 2023
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 235,878.62 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. 76,960.86 4,624.15 +1.3%
Divi's Laboratories Ltd. 75,014.78 2,826.00 +0.3%
Cipla Ltd. 72,696.02 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. 61,962.56 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. 52,030.91 1,543.40 +0.2%
Zydus Lifesciences Ltd. 49,749.83 491.00 +0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 56.00 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 21.13 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-12 31.30 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-12 27.55 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 81.03 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.86 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 24.11 491.00 +0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.26 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.50 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-12 6.03 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-12 3.20 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.04 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.19 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.88 491.00 +0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 0.04 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 491.00 +0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 491.00 +0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 491.00 +0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 491.00 +0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 491.00 +0.1%

FAQ's On Shree Pacetronix Ltd.

What is Shree Pacetronix share price?
Can I buy Shree Pacetronix shares now?
What is the Market Cap of Shree Pacetronix?
What are the key metrics to analyse Shree Pacetronix?
What is the 52 Week High and Low of Shree Pacetronix?
What is the trend of Shree Pacetronix share price?